Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dean J. Mitchell currently holds 13,398 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dean J. Mitchell has been a net seller of TBPH stock. They have purchased $591.7K and sold $2.1M worth of shares.
Dean J. Mitchell's most recent insider trade was on Jun 12, 2026, when they sold 13,398 shares at $0.00 per share.
Dean J. Mitchell serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 143 insider transactions totaling $2.6M over their tenure at the company.
Dean J. Mitchell holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Dean J. Mitchell has shown a selling trading pattern, with $591.7K in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Dean J. Mitchell was on Sep 24, 2025, when they sold $379.0K worth of PRAX shares. This transaction involved 8,566 shares at $44.25 per share.
Dean J. Mitchell currently owns 13,398 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dean J. Mitchell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dean J. Mitchell has 143 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Dean J. Mitchell and 40,000+ other insiders.